Robert A. Parise

Evaluation of Atypical Cytochrome P450 Kinetics with Two-Substrate Models:  Evidence That Multiple Substrates Can Simultaneously Bind to Cytochrome P450 Active Sites

Ken Korzekwa, N. Krishnamachary, Magang Shou et al. · Biochemistry · 1998 · 519 citations

Medicine, Pharmacokinetics, Pharmacology +17

Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

Suresh S. Ramalingam, Robert A. Parise, Ramesh K. Ramananthan et al. · Clinical Cancer Research · 2007 · 196 citations · Full text

Medicine, Oncology, Pharmacology +17

Sulforaphane Inhibits Prostate Carcinogenesis and Pulmonary Metastasis in TRAMP Mice in Association with Increased Cytotoxicity of Natural Killer Cells

Shivendra V. Singh, Renaud Warin, Dong Xiao et al. · Cancer Research · 2009 · 193 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction: A Study by the National Cancer Institute Organ Dysfunction Working Group

Joseph Gibbons, Merrill J. Egorin, Ramesh K. Ramanathan et al. · Journal of Clinical Oncology · 2008 · 135 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Sensitive liquid chromatography–mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma

Robert A. Parise, Ramesh K. Ramanathan, William C. Zamboni et al. · Journal of Chromatography B · 2002 · 128 citations

Pharmacy, Pharmacokinetics, Pharmacology +11